Last reviewed · How we verify

Phenoterol — Competitive Intelligence Brief

Phenoterol (FENOTEROL) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: fenoterol. Area: Other.

marketed fenoterol Beta-2 adrenergic receptor, Beta-2 adrenergic receptor Other Small molecule Live · refreshed every 30 min

Target snapshot

Phenoterol (FENOTEROL).

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Phenoterol TARGET FENOTEROL marketed fenoterol Beta-2 adrenergic receptor, Beta-2 adrenergic receptor
ProAir albuterol Generic (originally Allen & Hanburys/GSK) marketed SABA (Short-acting beta-2 agonist) Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-2 adrenergic receptor 1982-05-05

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (fenoterol class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Phenoterol — Competitive Intelligence Brief. https://druglandscape.com/ci/fenoterol. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: